ArticlePDF Available

Bacillus Coagulans Enhance the Immune Function of the Intestinal Mucosa of Yellow Broilers

Authors:

Abstract and Figures

This experiment was conducted to investigate the effects of Bacillus coagulans on the growth performance and immune functions of the intestinal mucosa of yellow broilers. Three hundred and sixty one-day-old yellow chicks were randomly allocated to four treatments groups with six replicates of 15 chicks each. The broilers were randomly subjected to one of the following treatments for 28 days: control group (group1, fed a basal diet) and three treatments (group 2, 3, 4) fed the basal diet supplemented with 100, 200, or 300 mg/kg Bacillus coagulans , respectively). The results showed that for 28 days, compared with the control diet, the dietary addition of 200 mg/kg Bacillus coagulans significantly decreased the feed/gain ratio (F/G) (p<0.05), improved the thymus index, spleen index and bursa index (p<0.05), increased the villus height to crypt depth ratio (V/C) in the duodenum (p<0.05), increased the number of secretory immunoglobulin (sIgA) positive cells ( p<0.05). The dietary addition of 200 mg/kg Bacillus coagulans promoted a significant increase in Lactobacillus spp. populations and suppressed Escherichia coli replication in cecum, compared with the control (p<0.05). Moreover, the dietary addition of 200 mg/kg Bacillus coagulans also significantly enhanced the levels of interferon alpha (IFNα), toll-like receptor (TLR3), and melanoma differentiation-associated protein 5(MDA5) in the duodenum (p<0.05). In conclusion, the dietary addition of Bacillus coagulans significantly improved broiler performance, and enhanced the intestinal mucosal barrier and immune function. The optimal dosage of Bacillus coagulans for yellow broilers was determined as 2×108 cfu/kg.
Content may be subject to copyright.
115
Brazilian Journal of Poultry Science
Revista Brasileira de Ciência Avícola
ISSN 1516-635X Jan - Mar 2017 / v.19 / n.1 / 115-122
http://dx.doi.org/10.1590/1806-9061-2015-0180
Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
Author(s)
Xu LI
Fan QI
Zhuang YI,II
Wang QI,II
Gao YI
Wang CI
I College of Animal Sciences – Fujian Agri-
culture and Forestry University, Fuzhou
350002, China.
II Fujian Key Laboratory of Traditional Chine-
se Veterinary Medicine and Animal Health
(Fujian Agriculture and Forestry University)
Mail Address
Corresponding author e-mail address
Quanxi Wang
College of Animal Sciences – Fujian
Agriculture and Forestry University, Fuzhou
350002, China.
Tel: (+086)059183758852
E-mail: wqx608@126.com
Keywords
Bacillus coagulans, yellow broilers, growth
performance, intestinal mucosa immune
function.
Submitted: August/2016
Approved: November/2016
ABSTRACT
This experiment was conducted to investigate the effects of Bacillus
coagulans on the growth performance and immune functions of the
intestinal mucosa of yellow broilers. Three hundred and sixty one-day-old
yellow chicks were randomly allocated to four treatments groups with
six replicates of 15 chicks each. The broilers were randomly subjected
to one of the following treatments for 28 days: control group (group1,
fed a basal diet) and three treatments (group 2, 3, 4) fed the basal
diet supplemented with 100, 200, or 300 mg/kg Bacillus coagulans,
respectively). The results showed that for 28 days, compared with
the control diet, the dietary addition of 200 mg/kg Bacillus coagulans
signicantly decreased the feed/gain ratio (F/G) (p<0.05), improved
the thymus index, spleen index and bursa index (p<0.05), increased
the villus height to crypt depth ratio (V/C) in the duodenum (p<0.05),
increased the number of secretory immunoglobulin (sIgA) positive
cells (p<0.05). The dietary addition of 200 mg/kg Bacillus coagulans
promoted a signicant increase in Lactobacillus spp. populations
and suppressed Escherichia coli replication in cecum, compared with
the control (p<0.05). Moreover, the dietary addition of 200 mg/kg
Bacillus coagulans also signicantly enhanced the levels of interferon
alpha (IFNα), toll-like receptor (TLR3), and melanoma differentiation-
associated protein 5(MDA5) in the duodenum (p<0.05). In conclusion,
the dietary addition of Bacillus coagulans signicantly improved broiler
performance, and enhanced the intestinal mucosal barrier and immune
function. The optimal dosage of Bacillus coagulans for yellow broilers
was determined as 2×108 cfu/kg.
INTRODUCTION
Moore rstly reported that the animal weight was signicantly
enhanced by the addition of antibiotics in the feed in 1946 (Moore et
al., 1946). In the 1950s, the Food and Drug Administration (FDA) of the
United States rstly approved antibiotics as feed additives, after which
they were widely applied in the poultry industry for the treatment and
prevention of bacterial diseases and as growth promoter. However, the
negative effects of the extensive use – and even abuse – of antibiotics
gradually emerged, such as antibiotic residues in meat (Smither et
al., 1980), bacterial resistance (Krushna Chandra Sahoo et al., 2010),
intestinal ora imbalance, and environmental pollution (Pan et al.,
2011), leading several countries to introduce legislation to limit the
application of antibiotics in animal feeds.
The ban on the use of antibiotics as feed additives is an inevitable
trend in China, and therefore, the research on alternatives for in-
feed antibiotics is urgent. At present, there are many studies on such
alternatives, such as benecial bacteria, prebiotics, enzymes, acidulants,
and plant extracts (Vahjen et al., 2007; Natsir et al., 2010). Probiotics
116
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
maintain intestinal ora balance, enhance the intestinal
barrier function (Anderson et al., 2010; Dai et al., 2012;
Furrie E., 2005), and the immune function. Probiotics
also can effectively improve the activity of interferon,
which stimulates the immune cells to produce specic
antibodies, such as sIgA, improve the discrimination of
immune system, and induce cytokine expression in T
and B lymphocytes and macrophages (Russell et al.,
2013). Rajput reported that the dietary inclusion of a
yeast (Saccharomyces boulardii) and Bacillus subtilis
signicantly increased the weights of the bursa and
the thymus, and increased the mRNA expression levels
of the occluding, cloudin 2 and cloudin 3 nucleotides,
the number of IgA-positive cells in the jejunum, as well
as the intestinal levels of interleukin (IL)-6, IL-10, tumor
necrosis factor (TNF) alpha, transforming growth factor
beta (TGFβ), and sIgA (Rajput et al.,2013).
Intestinal-related immune system can identify gut
microbes by pattern recognition receptors (PRRs), such
as toll-like receptors (TLRs) (Gómez-Llorente et al.,
2010). Probiotics can activate the mitogen-activated
protein kinase (MAPK) and nuclear factor kappa(NF-
kB) to activate TLRs, thereby regulating the immune
function (Lebeer et al., 2010; Kawai et al., 2010; Wells
et al., 2011). Probiotics can also regulate the immune
function by regulating the inammatory reaction
(Castillo et al., 2011).
In this experiment, the effect of Bacillus coagulans
on the growth performance and the immune function
of the intestinal mucosa of yellow-feathered broilers
was investigated.
MATERIALS AND METHODS
Birds and management
A total of 360 one-day-old healthy Lingnan yellow-
feathered chickens were provided by Guangdong
Wens Food Group Co., Ltd.
The experiment was performed at the poultry
laboratory of Fujian Agriculture and Forestry University
in Fuzhou, Fujian province, China. Fifteen chickens
were reared per cage equipped with a drinker and a
feeder. The water changed and feed was added to the
feeders once daily. Birds were submitted to 23 hours of
light. Vaccination was carried out according to Table 1.
Bacillus coagulans powder, containing that
contained 1×109cfu/g living bacteria, was provided by
Luodong Bio-Technology CO. LTD.
Experiment design
Chickens were randomly divided into four
treatments with six replicates of 15 birds each. The
chickens in the control group (group 1) were fed with
a basal diet, and those in other groups (groups 2, 3, 4)
were fed with the basal diet supplemented with 100,
200, or 300 mg/kg Bacillus coagulans, respectively. The
experiment lasted for 28 days.
The basal diet was formulated according to China’s
poultry industry standards for Chinese color-feathered
chicken between 1 to 28 days old. The diet was formu-
lated for the entire period and supplied as mash. The
Bacillus coagulans powder was added in the premix.
The composition of the basal diet is shown in Table 2.
Table 2 – Composition and nutrient level of basal diet (air
dry basis) %
Items Content(0-28d)%
Corn 58
Soybean meal 27
Expanded soybean 10
Limestone 1.0
Premix14.0
Total 100.0
Nutrient levels
Metabolizable Energy (ME), MJ·kg-1 11.87
Crude Protein (CP), % 21.20
Calcium (Ca), % 1.02
Total Phosphorus (TP), % 0.55
Available Phosphorus (AP), % 0.31
Lysine (Lys), % 1.12
Methionine (Met) + Cystine (Cys), % 0.83
1) The nutrient values in the table are calculated values.
2) The premix supplied per kg diet: Cu (as copper sulfate) 10mg, Fe (as ferrous sulfa-
te) 72mg, Zn (as zinc sulfate) 60.2mg, Mn (manganese) 78mg, I (iodine) 0.4mg, Se
(selenium) 0.24mg, choline 600mg, Vit. A (Vitamin A) 10000IU, Vit. D3 (Vitamin D3)
2600IU, Vit. E (Vitamin E) 26mg, Vit. K3 (Vitamin K3) 2.6mg, Vit. B1 (Vitamin B1) 2.6mg,
Vit. B2 (Vitamin B2) 6.5 mg, Vit. B6 (Vitamin B6) 2.60mg, Vit. B12 (Vitamin B12) 19.5μg,
nicotinic acid 26mg, D-pantothenic acid 13mg, Folic acid 1.3mg, biotin 104μg,
methionine 2364IU.
Table 1 – The immune program
Age Vaccine Dose Immune method
1 day old Marek’s disease vaccine
Combined vaccination of Newcastle disease and infectious bronchitis
One feather
One feather
Intramuscular injection
Eye droppings
5 day old Avianinuenzavaccine
Fowlpox vaccine
One feather
One feather
Intramuscular injection
Hypodermic injection
10 day old Newcastle disease vaccine One feather Intramuscular injection
20 day old
infectious bursal disease vaccine
Newcastle disease vaccine
Avianinuenzavaccine
One feather
One feather
One feather
eye droppings
Intramuscular injection
Intramuscular injection
117
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
Growth performance parameters
Chicks were individually weighed on day 1 of the
trial, and no signicant differences were detected. On
day 28, chicks were fasted for 12h and individually
weighed. Feed was offered daily at 5:00 pm, after feed
residues were measured. Average daily feed intake,
average daily weight gain, and feed to gain ratio were
calculated per experimental group. Livability (%) was
calculated weekly.
Immune organ index
On day 28, three chicks in per replicate were selected
and sacriced by decapitation. The thymus, spleen and
bursa were collected and weighed. Thymus, spleen,
and bursa indexes were calculated as = [organ weight
(g)/ body weight (g)] ×100.
Bacterial flora detection in the cecum by
SYBR-PCR
Standard curve preparation
Plate count: Escherichia coli strain k88 was used as
reference strain. It was cultured in lysogeny broth (LB)
at 37 oC for 7 h, and then was serially diluted to 10-9.
Dilutions were then cultured in Macconkey medium at
37oC for 24 h. Finally, bacterial colonies were counted.
Standard curve: The DNA of Escherichia coli strain
k88 was serially diluted to 10-6., and was detected by
Quantitative Real-time Polymerase Chain Reaction
(SYBR-PCR), and the linear equation was calculated.
Detection of Escherichia coli and
Lactobacillus spp.
The universal primers of bacterial genera and
the specic PCR primers of Escherichia coli and
Lactobacillus genus were designed (Table 3). On day
28, the cecal content (200 mg) from the three chicks
per replicate sacriced for organ index were collected,
and total DNA was extracted using a genomic DNA
extraction kit (Taingen, Beijing, China). Escherichia
coli and Lactobacillus spp. in the cecal content were
detected by SYBR-PCR.
Reaction volumes of 25 μL consisted of 12.5 μL
SYBR® Premix Ex TaqTM (2×) (Promega, Wisconsin,
U.S.A), ROX reference dye ( 50× ) 0.5 μL, 1 μLDNA,
1 μL forward primer (10 μM), 1 μL reverse primer (10
μM), and 10 μL RNase free ddH2O. PCR conditions were
initial denaturation at 95oC for 0.5 min followed by 40
cycles at 95oC for 5 s, 60oC for 34 s, and 95oC for 15
s, 60oC for 1 min, 95oC for 15 s. Data was calculated
by delta delta CT(rrCT), and were analyzed by
SPSS19.0.
Villus height / crypt depth ratio
On day 28, three birds per treatment were
sacriced for organ index determination, and the
intestinal contents were rinsed with physiological
saline (PBS, 0.01mol/L, pH=7.1). Duodenal sections
(1.5cm×1.5cm×0.5cm) were collected, xed in 4%
paraformaldehyde xing solution for 24 hours, and
were submitted to routine histology procedures,
including dehydration, clearing, and embedding
in parafn. Samples were cut into 4 to 6μm semi-
serial cross sections and stained with hematoxylin
and eosin (HE). Intestinal villus height and crypt
depth were measured under an optical microscope
at 40x magnication using the software HPIAS-5100
(Qianping, Shanghai, China).
Detection of sIgA by immunohistoche-
mistry
The sections of duodenum from the chicks sacriced
for organ index were prepared and inhibited by
preincubating the tissues in 3% H2O2, incubated in 5%
normal goat serum for 0.5h followed by
an overnight incubation at 4oC with 1:40
dilution of rabbit anti-chicken IgA serum.
Sections were then incubated with goat
anti-rabbit IgG (1:300, Vektor ABC kit,
PK-6101) at room temperature for 1h,
followed by incubation with an avidin-
biotin-peroxidase conjugate solution at
room temperature for 1h. The sections
were then rinsed three times with
phosphate salt buffer (PBS) and were
incubated with 3,3’-diaminobenzidine
tetrahydrochloride (Sigma, Calif, U.S.A)
solution dissolved in 0.05 M Tris-HCl
buffer (pH 7.4) at room temperature.
Table 3 – Primer sequences
Items Primer sequences Amplied
fragments(bp)
Bacterium universal primer (16s) F: 5’-CCTACGGGAGGCAGCAG-3
R: 5’-ATTACCGCGGCTGCTGG-3194
Escherichia coli(16s) F: 5’-GTTAATACCTTTGCTCATTGA-3
R: 5’-ACCAGGGTATCTTAATCCTGTT-3340
Lactobacillus genus(16s) F: 5’- AGCAGTAGGGAATCTTCCA-3
R: 5’ -CACCGCTACACATGGAG -3341
IFN-αF: 5’ -GGACATGGCTCCCACACTAC-3
R: 5’ -ATCCGGTTGAGGAGGCTTT-3204
TLR3 F: 5’ -CCATTTGATTGCACCTGTGA-3
R: 5’ -GCAACACCAGAGTACCGTGA-3133
MDA5 F: 5’ -GAAGAAGGTGTCCGCTTATCA-3
R: 5’ -GAATCTGAGGCTGTGGAATCA-3169
β-actin F: 5’ -CCAAAGCCAACAGAGAGAAGAT-3
R: 5’ -CATCACCAGAGTCCATCACAAT-3138
118
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
Ten minutes later the enzyme-substrate reaction were
stopped with 0.05M Tris-HCl buffer (pH 7.4). Sections
were then rinsed in PBS and counterstained with
hematoxylin. Finally, sections were cleared and sealed
with a glass coverslip. In the duodenum, IgA-positive
lymphocytes were identied by their characteristic
morphology: round, with a nucleus surrounded by a
yellow-brown stained ring.
Expression of INF, TLR-3 and MDA-5 mRNA
Quantitative real-time PCR was performed with
the primers shown in Table 3 to analyze the mRNA
expression levels of interferon (IFN) and pattern
recognition receptors (TLR-3, MDA-5) to verify if the
Bacillus coagulans product stimulated
interferon production to enhance
intestinal mucosal immune function.
Data was calculated and analyzed by
rrCT.
RESULTS
Growth performance
Table 4 shows the performance results
obtained during the 28 days of the
experiment. Average daily feed intake
was not different among treatments
(p>0.05). Average daily weight gain
was 0.40% (p>0.05), 3.75% (p<0.05),
3.23% (p>0.05) higher in groups 2,
3, and 4, respectively, compared with
group 1. Average body weight gain of
group 3 was 3.73% higher than in group
1 (p<0.05). The feed conversion ratio of
group 3 was 2.55% lower than that of
group 1 (p<0.05). Compared with group
1, groups 2, 3 and 4 presented 1.15%,
1.15%, and 2.30% survival rates,
but the difference was not signicant
(p>0.05). These results showed that the
growth performance of chickens fed
with 200 mg/kg Bacillus coagulans was
signicantly enhanced.
Immune organ index
Immune organ index indicates status of the avian
immune function. As shown in Table 5, the thymus
index of groups 2, 3, and 4 was 7.18% (p<0.05),
7.27% (p<0.05), and 0.56% (p>0.05) higher compared
with group 1. The spleen index of groups 2, 3, and 4
was 2.75% (p<0.05), 14.66% (p<0.05), and 10.91%
(p>0.05), respectively, higher than that of group 1.
The bursa index of groups 2, 3, and 4 was 14.24%,
14.28%, 14.24% (p<0.05) than that of group 1. These
results conrm that the dietary inclusion of 100 and
200 mg/kg Bacillus coagulans can signicantly increase
the immune organ index of chickens, particularly at
200 mg/kg.
Table 4 – Effects of Bacillus coagulans on the growth performance in yellow broilers
Treatments Average daily feed intake Average daily weight gain Feed conversion ratio Survival rate
1 29.75±0.81 15.18±0.46b1.96±0.04a 96.67±3.65
2 29.70±0.68 15.24±0.30ab 1.95±0.05ab 97.78±3.44
3 30.14±0.82 15.75±0.44a1.91±0.02b97.78±3.44
4 30.52±0.85 15.67±0.48ab 1.95±0.02 ab 98.89±2.72
Means followed by different superscripts in the same column are statistically different (p<0.05).
Figure 1 – Bacillus coagulans optimized the bacterial ora in the yellow
feather broiler chickens
A: Primer specicity identication showed that the designed primers can be used for real-time uorescence
quantitative PCR reaction. (1: Escherichia; 2: Negative control of Escherichia; 3: Lactobacillus; 4: Negative control
of Lactobacillus; M: 2000 DNAmarker)
B: Standard curve of standard samples (Escherichia Coli. strain k88 DNA)
C: Melting curve of standard sample
D: Amplication curve of standard sample
E: Melting curve of E. coli
F: Melting curve of Lactobacillus
119
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
Table 5 – Effects of Bacillus coagulans on the immune
organ index (%) of yellow broilers
Treatments Thymus index Spleen index Bursal index
1 0.4292±0.0435a0.1623±0.0216a0.2844±0.0466a
2 0.4600±0.0246b0.1830±0.0236b0.3249±0.0345b
3 0.4604±0.0277b0.1861±0.0264b0.3250±0.0517b
4 0.4316±0.0393ab 0.1800±0.0194ab 0.3249±0.0432b
Means followed by different superscripts in the same column are statistically different
(p<0.05).
Cecal bacterial flora
Plate count results showed that the number of
Escherichia coli strain k88 in the cecum was 1.6×1010
cfu/mL. The regression coefcient (R2) of the curve
was 0.9994, indicating that the counts were linearly
correlated with the dietary inclusion levels of the
product. The equation of the standard curve was y=-
3.006x+43.031 (y: Ct value’x: log value of standard
DNA samples).
Total bacterial counts in three groups fed with three
different doses Bacilllus coagulans were not different
(p>0.05) compared with the control group (Table 6).
Escherichia coli counts in the cecum of broilers were
not signicantly different among treatments (p>0.05).
However, Lactobacillus spp. counts were signicantly
increased in the cecum of broilers fed with 200 mg/kg
Bacillus coagulans in basal diet (p<0.05).
Table 6 – Effects of Bacillus coagulans on the microbial
ora ( lgcfu·g-1 ) of yellow broilers.
Treatments Total bacterial count Escherichia coli Lactobacillus spp.
1 11.85±0.21 10.67±0.38 9.34±1.14a
2 11.87±0.13 10.36±0.32 9.73±1.16ab
3 11.88±0.22 10.42±0.41 10.18±0.76b
4 11.84±0.19 10.37±0.41 9.40±0.78ab
Means followed by different superscripts in the same column are statistically different
(p<0.05)
Duodenal villus to crypt ratio
On day 28, intestinal villus height in three groups
fed with three doses of Bacilllus coagulans was not
different change compared with the control group
(p>0.05), but the duodenal crypts of group 3 were
signicantly deeper compared with the control group
(p<0.05). Therefore, the villus height to crypt depth
ratio (V/C) value was higher in the duodenum of
broilers fed with 200 mg/kg Bacillus coagulans in the
basal diet (Table 7).
Table 7 – Effects of Bacillus coagulans on the villus height
to crypt depth ratio (V/C value) of duodenum in yellow
broilers.
Treatments Intestinal villi
height (μm) Crypt depth (μm) V/C value
1 1120.91±41.24 114.48±8.54a9.83±0.78a
2 1157.63±35.33 108.93±7.75ab 10.68±0.96ab
3 1160.20±45.00 103.39±9.19b11.30±1.11b
4 1134.50±28.22 105.79±7.54ab 10.76±0.72ab
Means followed by different superscripts in the same column are statistically different
(p<0.05)
Levels of sIgA-positive cells lever in
duodenum
In the duodenum, sIgA-positive lymphocytes were
identified by immunohistochemistry. These cells were
present in the lamina propria of duodenal villi (Fig. 2
A-D). Fig. 2 E shows that there were more sIgA-positive
cells in the duodenum of group 3 (p< 0.05) compared
with group 1. No differences were observed between
the other groups (p>0.05).
mRNA expression of IFN-α, MDA-5 and
TLR-3
A-D: SIgA-positive lymphocytes were identified by immunohistochemistry method with
characteristic antibody. These cells were present in the lamina propria of villi in the
duodenum. A: group I, B: group II, C: group III, D: group IV. E: Statistical analysis on the
number of SIgA-positive cells. *: p< 0.05.1-4: group I-IV.
Figure 2 – Bacilllus coagulans increase SIgA-positive cells in the duodenum
IFN-α is an important immune regulator, and may
stimulate the innate immune and antiviral responses.
120
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
The objective of this measurement was to investigate if
the Bacilllus coagulans was able to regulate the innate
immune function of the intestinal tract. The results
showed that, on day 28, the mRNA expressions of IFN-α,
MDA-5 and TLR3 were signicantly higher in group 3
compared with group 1 (p<0.05 or p<0.01) (Fig. 3),
indicating that Bacilllus coagulans may stimulate the
innate immune function of the intestinal tract.
A: IFN- α, B: MDA5, C: TLR3, 1: group I, 2: group II, 3: group III, 4 group IV
Figure 3 – Bacilllus coagulans promoted the mRNA expression of IFN-α, MDA5 and
TLR3
DISCUSSION
The results of this experiment showed that the
growth performance of chickens fed 200 mg/kg
Bacilllus coagulans was effectively improved, which
is consistent with the other reports. Lei reported
that the dietary inclusion of spores of a lactobacillus
improved the conversion ratio and reduced mortality
and culling rate of broilers (Lei et al., 2015). Lactobacilli
improve calcium and phosphorus utilization, and lactic
acid promotes the transformation of pepsinogen
into protease, stimulating the peristalsis of the small
intestine to enhance nutrient digestion (Ma et al.,
2014; Giang et al., 2010).
Thymus, spleen, and bursa of Fabricius are important
immune organs of poultry, and their index reects the
immune function of the poultry. Our results are in
agreement with the ndings of Jin Er-hui (2013), who
showed that the 21-day old and 42-day old AA chickens
fed] a bacillus-based probiotic contained 1x1011cfu/g
provided by Jiaxing Kori Biological Technology Co., LTD
at 200 mg/kg presented better development of the
immune organs and immune function than 400 mg/
kg (Jin et al., 2013). Other studies have shown that
Bacillus spp. regulate the intestinal bacterial ora and
improve the immune function of the intestinal mucosa
(Isolauri et al., 2001).
The ceca are the main site of intestinal microbial
replication and activity. Lactobacillus spp. and
bidobacteria are the predominant genera (Apajalahti
et al., 2004). These are commensal bacteria and can
suppress the harmful bacteria and inammation
(Sheil et al., 2007). Escherichia coli is a conditionally
pathogenic bacterium, and may become harmful and
cause diarrhea when the intestinal microbial ora is
imbalanced (Zhang et al., 2010).
Bacillus coagulans is able to produce bacteriocins,
such as lactosporin, which have signicant antibacterial
activity (Riazi et al., 2009). In addition, it produces
lactic acid and other organic acids, reducing the
colonization of harmful bacteria in the intestinal tract
(Cui et al., 2005). Bacillus coagulans also breaks down
polysaccharides into oligosaccharides, promoting
the growth of lactobacilli, bidobacteria and other
benecial bacteria, maintaining intestinal ora balance
(Zheng et al.,2011). In recent years, a new compound,
dysprosium, produced from Bacillus coagulans was
shown to have broad antibacterial spectrum and to
be highly efcient (Honda et al., 2011). Studies found
that morphological changes in the small intestine were
closely related to a toxin produced by enterotoxigenic
Escherichia coli (ETEC) in the gut Jindal et al.,2006.
The small intestine is the main organ for the digestion
and absorption of nutrients. Villus height, crypt depth
and V/C ratio are indication of nutrient absorption
capacity by the intestine (Caspary et al., 1992). In the
present experiment, there was a positive and signicant
correlation between the intestinal villus height and the
number of epithelial cells. Increases in the number of
intestinal epithelial cells and in villus height indicates
better nutrient absorption capacity ability of the body
enhanced. Crypt depth reects the secretory function
of small intestine. Bacillus spp. can stimulate the
differentiation and proliferation of intestinal epithelial
cells and improve nutrient utilization (Artis et al., 2008;
Wells et al., 2011; Duerr et al., 2012). Lei reported
that broilers receiving a direct-fed microbial based
on Bacillus amyloliquefaciens signicantly increased
crypt depth and villus height to crypt depth ratio in
the duodenum, jejunum, and ileum (Lei et al., 2015).
Similarly, in broilers fed diets with 200 mg/kg Bacillus
coagulans, an increase in V/C ratio was also observed
(Lin et al., 2014).
The function of the intestinal barrier is to maintain
epithelial integrity and to protect the body from the
environment. The intestinal barrier functions include
the mucous layer, secretory IgA and epithelial junction
adhesion complex (Miriam et al., 2012). If this barrier
is disrupted, antigens reach the submucosa and induce
121
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
inammatory response (Wang et al., 2012). The
integrated intestinal mucosa barrier is important for
the defense against pathogenic bacteria (Blikslager et
al., 2007).
Secretory IgA is produced and secreted by IgA-
positive plasma cells in the lamina propria of the
intestinal mucosa. It is released in the intestinal
lumen and mixed with the normal ora. It allows the
establishment of the normal ora and inhibit pathogen
colonization. Medici fed BALB mice with probiotic
fresh cheese (PFC) and found the PFC enabled
Bifidobacterium bifidum, Lactobacillus acidophilus and
L. paracasei to exert important immunomodulating
effects in the gut (Medici et al.,2004). In our study,
the number of IgA-positive cells was signicantly
increased when broilers were fed 200 mg/kg Bacillus
coagulans, suggesting that this probiotic may enhance
the immune function of the intestinal mucosa.
The intestinal mucosa is rich in lymphoid tissues,
called the gut-associated lymphoid tissue (GALT). GALT
can secret multiple cellular factors, such as interferon,
colony stimulating factors (CSFs), interleukins, etc.,
which are able to kill pathogens and regulate the
immune function of the mucosa. Interferons, in
particularly, mediate the innate immune. Interferons are
produced in response to pathogen infection. However,
the infecting pathogen need to be recognized by
pattern recognition receptors (PRRs), such as toll-like
receptors (TLRs), melanoma differentiation-associated
protein 5 (MDA-5)-like receptors, increasing the
expression of IFN type I in the infected cells. MDA5 is
one of the most important PRRs (Durbin et al.,2013).
MDA-5 plays the critical role in the recognition of
pathogens in the cytoplasm and transmits a signal
to induce expression of interferon and cytokines. The
newly-synthesized IFN-I is then secreted and binds to
the IFN-I receptor (IFNAR), inducing the expression of
hundreds of IFN stimulating genes (ISGs) that promote
immune regulation.
Kailova reported that mice suffering from
necrotizing enterocolitis (NEC) were orally received
Bidobacterium OLB 6378, which stimulated the
mRNA expression of TLR2, cyclo-oxygenase2 (COX-2),
and increased the synthesis intestinal of prostaglandin
estradiol 2 (Kailova et al.,2010). Liu also veried that
Roy’s lactobacillus DSM 17938 rat NEC has a positive
effect on the prevention on rat NEC, which can
signicantly reduce the mRNA expression of TNF alpha
and TLR 4 and TNF alpha, TLR 4 protein levels (Liu et al.,
2012). Rajput veried that boundens yeast and bacillus
B10 stimulated chicken bone marrow dendritic cells,
increasing TLR 1, TLR 2, TLR 4, and TLR 15 expression
(Rajput et al., 2014).
Bacillus coagulans not only has the characteristics
of lactobacilli and bidobacteria, but is also resistant to
acid environments and high temperatures (Hyronimus
et al., 2000; Ripamonti et al., 2009). Previous
experimental studies showed that Bacillus coagulans
was able to regulate cell factors, enhanced the
phagocytosis of phagocytic cells, enhanced the activity
of NK, T and B cells, and increased the expression of
IgA, IgG and IgM (Kodali et al., 2008). Consistently, the
results of the present experiment showed that Bacillus
coagulans can enhance the immune function of the
gut of yellow-feathered broilers.
ACKNOWLEDGMENTS
This work was supported by a program from
China Fujian laying hen industry system program (NO.
K83139297 (2013-2017)).
REFERENCES
Anderson RC, Cookson AL, McNabb WC, Park Z, Mccann MJ. Lactobacillus
plantarum MB452 enhances the function of the intestinal barrier by
increasing the expression levels of genes involved in tight junction
formation. BMC Microbiology 2010; 10: 316.
Apajalahti J, Kettunen A, Graham H. Characteristics of the gastrointestinal
microbial communities, with special reference to the chicken. World
Poultry Science Journal 2004;60 (2): 223-232.
Jindal A, Kocherginskaya S, Mehboob A, Robert M,Mackie RI,Zillles LR.
Antimicrobial use and resistance in swine waste treatment systems.
Applied and Environmental Microbiology 2006;72 (12): 7813-7820.
Artis D. Epithelial-cell recognition of commensal bacteria and maintenance
of immune homeostasis in the gut. Nature Reviews Immunology
2008;8 (6): 411-420.
Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier
function in injured intestinal mucosa. Physiological Reviews 2007;87(2):
545–564.
Caspary WF. Physiology and pathophysiology of intestinal absorption.
American Journal of Clinical Nutrition 1992; (55): 299-308.
Castillo NA, Perdigón G, Leblanc A de M. Oral administration of a probiotic
Lactobacillus modulates cytokine production and TLR expression
improving the immune response against Salmonella enterica serovar
typhimurium infection in mice. BMC Microbiology 2011; 11: 177-189.
Cui YL, Run SC, Wan FC. Bacteriostasis of Bacillus coagulans TBC 169 to
enteropathogenic bacteria. Chinese Journal of Microecology 2005; 17
(5): 333-338.
Dai C, Zhao D H, Jiang M. VSL3 probiotics regulate the intestinal epithelial
barrier in vivo and in vitro via the p38 and ERK signaling pathways.
International Journal of Molecular Medicine 2012; 29 (2): 202-208.
Duerr CU, Hornef MW. The mammalian intestinal epithelium as integral
player in the establishment and maintenance of host-microbial
homeostasis. Seminars Immunology 2012; 24 (1): 25-35.
122
Xu L, Fan Q, Zhuang Y,
Wang Q, Gao Y, Wang C Bacillus Coagulans Enhance the Immune Function of
the Intestinal Mucosa of Yellow Broilers
Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O’Neil DA.
Synbiotic therapy ( Bidobacterium longum/Synergy 1) initiates
resolution of inammation in patients with active ulcerative colitis: a
randomised controlled pilot trial. Gut 2005; 54(2): 242-249.
Gómez-Llorente C, Muñoz S, Gil A. Role of Toll-like receptors in the
development of immunotolerance mediated by probiotics. Proceeding
of Nutrition Society 2010; 69(3): 381-389.
Giang HH, Viet T Q, Linberg J E, Linberg JE. Groeth performance,
digestibility, gut environment and health status in weaned piglets fed
a diet supplemented with potentially probiotic complexes of lactic acid
bacteria. Livestock Science 2010;129(1-3): 95-103.
Honda H, Gibson GR, Farmer S, Keller D, McCartney AL. Use of a continuous
culture fermentation system to investigate the effect of GanedenBC30
(Bacillus coagulans GBI-30, 6086) supplementation on pathogen
survival in the human gut microbiota. Anaerobe 2011; 17 (1): 36-42.
Hyronimus B, Le Marrec C, Sassi AH, Deschamps A. Acid and bile tolerance
of spore-forming lactic acid bacteria.International Journal of Food
Microbiology 2000;61(2-3):193-197.
Isolauri E, Sutas Y, Kankaanpaa P,Arvilommi H,Salminen S. Probiotics:
effects on immunity. American Journal of Clinical Nutrition 2001; 72
(2): 444-450.
Jin Er-hui, Chen Yao-xing,Wang Qun,Qiao En-mei,Wu Guo-zhong,Li
Sheng-he. Effect of the bacillus probiotics on blood cells anf structure
of immune organs in broilers. Acta veterinaria et zootechnica
sinica2013;44(5):778-787.
Kailova L, Mount Patrick SK, Arganbright KM, Halpem MD, Kinouchi
T,Dvorak B. Bidobacterium bidum reduces apoptosis in the intestinal
epithelium in necrotizing enterocolitis. American Journal of Physiology
Gastrointestinal Liver Physiology 2010; 299(5):1118-1127.
Kawai T, Akira S. The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nature Immunology 2010;11:
373-384.
Kodali VP, Sen R. Antioxidant and free radical scavenging activities of an
exopolysaccharide from a probiotic bacterium. Journal of Biotechnology
2008;3(2): 245-251.
Sahoo KC, Tamhankar AJ, Johansson E, Lundborg CS. Antibiotic use,
resistance development and environmental factors: a qualitative study
among healthcare professionals in Orissa, India. BMC Public Health
2010; 10(1):1-10.
Lebeer S, Vanderleyden J, De Keersmaecker CJ. Host interactions of
probiotic bacterial surface molecules: comparison with commensals
and pathogens. Nature Review Microbiology 2010; 8(3): 171-184.
Lei XJ, Piao X , Ru Y, Zhang H, Peron A, Zhang H. Effect of bacillus
amyloliquefaciens-based direct-fed microbial on performance, nutrient
utilization, intestinal morphology and cacal microora in broiler
chickens. Asian-Australasian Journal of Animal Science 2015;28(2):239-
246.
Lin LH, Ke FR, Zhan TT, Xu LH, Wang QX, Wang CK, Huang SW. Effects
of Bacillus coagulans on Performance, Serum Biochemical Indices and
Antioxidant Function of Yellow Broilers. Chinese Journal of Animal
Nutrition. 2014, 26(12): 2806-2813.
Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Lactobacillus reuteri strains
reduce incidence and severity of experimental necrotizing enterocolitis
via modulation of TLR4 and NF- κB signaling in the intestine. American
Journal of Physiology Gastrointestinal Liver Physiology 2012; 302(6):
608-617.
Ma K, Maeda T, You H, Shirai Y. Open fermentative production of L-lactic
acid with high optical purity by thermophilic Bacillus coagulans using
excess sludge as nutrient. Bioresource Technology 2014;151: 28-35.
Medici M, Vinderola C, Perdigon G. Gut mucosal immunomodulation by
probiotic fresh chess. International Dairy Journal 2004,14(7):611-618.
Miriam BB, Julio PD, Sergio MQ, Carolina G L, Angel G. Probiotic Mechanisms
of Action. Annal of Nutrition Metabolism 2012;61:160–174.
Moore PR, Evension A, Luckey TD, Mccoy E, Elvehjem CA, Hart EB. Use
of sulfasuxidine, streptothricin and streptomycin in nutritional studies
with the chick.The Journal of Biological Chemistry 1946;165: 437-441.
Natsir MH, Sjofjan O, Umam K, Manab A, Widodo E. Effects of liquid and
encapsulated lactic acid in broiler diets on performances, intestinal
characteristics and intestinal microora.The Journal of Poultry Science
2010; 47: 240-243.
Pan X, Qiang Z, Ben W, Chen M. Residual veterinary antibiotics in swine
manure from concentrated animal feeding operations in Shandong
Province, China. Chemosphere 2011; 84 (5): 695-700.
Rajput IR, Li LY, Xin X, Wu BB, Juan ZL, Cui DY, Li WF. Effect of Saccharomyces
boulardii and Bacillus subtills B10 on intestinal ultrastructure modulation
and mucosal immunity development mechanism in broiler chickens.
Poultry Science 2013;92 (4): 956-965.
Rajput IR, Hussain A, Li YL, Zhang X, Xu X, Long MY, You DY, Li WF.
Saccharomyces boulardii and Bacillus subtilis B10 modulate TLRs
mediated signaling to induce immunity by chicken BMDCs. Journal of
Cell Biochemistry 2014; 115 (1): 189-198.
Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Characterization of
lactosporin, a novel antimicrobial protein produced by Bacillus
coagulans ATCC 7050. Journal of Applied Microbiology 2009; 106(4):
1370-1377.
Ripamonti B, Agazzi A, Baldi A, Balzaretti C, Bersani C, Pirani S, Rebucci R,
Savoini G, Stilla S, Stenico A, Domeneghini C. Administration of Bacillus
coagulans in calves:recovery from faecal samples and evaluation of
functional aspects of spores. Veterninary Research Communication
2009; 33(8):991-1001.
Durbin RK, Kotenko SV, Durbin JE.Interferon induction and function at the
mucosal surface. Immunological reviews 2013;255(1): 25-39.
Sheil B, Shanahan F, Omahony L. Probiotic effects on inammatory bowel
disease. The Journal of Nutrition 2007; 137 (3): 819S-824S.
Smither R, Lott AF, Dalziel RW, Ostler DC. Antibiotic residues in meat in the
United Kingdom; an assessment of specic tests to detect and identify
antibiotic residues. Journal of Hygiene, Camb 1980; 85(3):359- 359.
Vahjen W, Osswald T, Schäfer K, Simon O. Comparison of a xylanase and a
complex of non starch polysaccharide-degrading enzymes with regard
to performance and bacterial metabolism in weaned piglets. Archives
of Animal Nutrition 2007; 61(2):90-102.
Wang N, Wang G, Hao JX, Ma JJ, Wang Y, Jiang XY, Jiang HQ.Curcumin
ameliorates hydrogen peroxide-induced epithelial barrier disruption
by upregulating heme oxygenase-1 expression in human intestinal
epithelial cells.Digestive Diseases and Science 2012;57(7):1792-1801.
Wells JM. Immunomodulatory mechanisms of lactabacilli. Microbial Cell
Factories 2011; 10 (suppl 1): S17.
Wells JM, Rossi O, Meijerink M, Baarlen P. Epithelial crosstalk at the
microbiota-mucosal interface. Proceedings of the National Academy
Sciences 2011;108 (1): 4607-4614.
Zhang L, Xu Y Q, Liu H Y, Lai T,Ma JJ, Wang JF,Zhu YH.Evaluation of
Lactobacillus rhamnosus GG using an Escherichia coli K88 model of
piglet diarrhoea: Effects on diarrhoea incidence, faecal microora and
immune responses. Vet Microbiol 2010; 141 (1-2): 141-148.
Zheng Z, Ma C, Gao C,Li F,Qin J, Zhang H,Wang K,Xu P. Efcient conversion
of phenylpyruvic acid to phenyllactic acid by using whole cells of
Bacillus coagulans SDM. PLoS One 2011;6 (4): e19030.
... In human medicine, Bacillus coagulans is primarily used to treat a broad range of different gastrointestinal disorders such as diarrhea, abdominal pain, digestive problems, and overgrowth of harmful bacteria (Jäger et al., 2018;Konuray and Erginkaya, 2018;Cao et al., 2020), but also immune system stimulation and improved respiratory health through Bacillus coagulans ingestion were reported (Baron, 2009;Anaya-Loyola et al., 2019). In animal production, these health-supportive effects (concomitant to a performance improvement and reduced mortality) were also observed in poultry nutrition when Bacillus coagulans was administered (Xu et al., 2017;Khajeh Bami et al., 2020;Zhang et al., 2021). The production of antimicrobial substances and hydrolases by Bacillus coagulans are additional modes of action that further support an intestinal eubiosis by directly and indirectly suppressing the growth of potentially harmful bacteria (Riazi et al., 2009;Maathuis et al., 2010;Honda et al., 2011;Abdhul et al., 2015). ...
... That these microbiotamodulating effects are mostly accompanied by improved overall performance (Hung et al., 2012;Lei et al., 2015;Alberoni et al., 2018;Li et al., 2019;Nour et al., 2021) further demonstrates the importance of a balanced microbiota and gut health for stable animal production. Bacillus coagulans is also known to stimulate the immune system which strengthens the immune defense and barrier function against a broad range of harmful bacteria such as C. perfringens (Xu et al., 2017;Guo et al., 2021). Furthermore, the microbial activity of Bacillus coagulans in the gut might (a) reduce oxidative stress and associated epithelial damage and (b) support the host lipid metabolism, glucose metabolism, liver function, epithelial growth, and absorp-tion of minerals (Lee et al., 2016;Wu, T. et al., 2018;Wu, S. et al., 2018;Li et al., 2019;Xing et al., 2020;Khajeh Bami et al., 2020;Nour et al., 2021). ...
Article
The worldwide application of antibiotic growth promotors in the last decades in animal production at least partly contributed to the global pool of multiantibiotic-resistant bacteria causing hardly treatable and severe human but also veterinarian infectious diseases. These circumstances prompted the development of alternative strategies to replace antibiotic growth promotors without losses in animal performance. Among other feed additives, health-beneficial live microorganisms (often designated as probiotics or gut microbiota stabilizers) became promising parts of such alternative approaches. This study aimed to investigate the effects of Bacillus coagulans DSM 32016 (1×10⁹ CFU/kg of diet) on the performance of broiler breeder (Arbor Acres). Broiler breeder hens (Arbor Acres; n=240) at the age of 22 weeks were randomly allocated to 1 of 2 dietary treatments with 12 replicates of 10 birds each, in a completely randomized design. Supplementation of the diet with Bacillus coagulans DSM 32016 increased the number of produced eggs, the number of produced settable eggs, egg yolk weighVt and eggshell thickness (P≤0.05). The probiotic supplementation reduced the mortality rate, enhanced egg hatchability, and increased the egg production-based economic profit. Thus, Bacillus coagulans DSM 32016 can be considered as performance-enhancing zootechnical feed additive for broiler breeders.
... acidophilus) (Li et al., 2018). Furthermore, Due to their ability to form spores, which produce resistance against high temperatures, pH, bile, and enzymes encountered in the gastrointestinal tract (GIT), withstand harsh conditions, and provide health benefits to the host, bacillus-based probiotics are widely used as antibiotic alternatives in animal and chicken feed (Haque et al., 2017, Xu et al., 2017. The research studies conducted to date in both challenged and non-challenged situations illustrate the opportunity for successfully using xylanase, amylase, protease, and bacillus strains in combination due to their complementary modes of action. ...
... The higher the villus height, the greater the V/C ratio, indicating a stronger capacity for digestion and absorption [50]. According to reports, the supplementation of Bacillus coagulans in piglets has been shown to significantly enhance the V/C ratio within the small intestine [9,51]. Similarly, the addition of tributyrin has been found to effectively increase both villus height and the V/C ratio in the intestinal tract of piglets [52]. ...
Article
Full-text available
Simple Summary Bacillus coagulans and tributyrin are important feed additives and both can improve the health of animals when used alone. Here, we found that the combination of Bacillus coagulans and tributyrin glycerin improved the antioxidant capacity, intestinal morphology, and composition of the intestinal microbiota of yellow-feathered broilers to a certain extent. We further found that these effects were synergistic. Overall, our study provided insight into the development of an effective and safe blend of feed additives in the poultry industry. Abstract This study investigated the impact of Bacillus coagulans (BC) and tributyrin (TB) supplementation on the growth performance, serum antioxidant capacity, intestinal morphology, and cecal microbiota of yellow-feathered broilers. Using a 2 × 2 factorial design, 480 broilers were randomly assigned to four experimental diets, comprising two levels of BC (0 and 1 g/kg) and two levels of TB (0 and 1 g/kg), over a 36-day period. A significant interaction was observed between BC and TB, impacting the average daily feed intake (ADFI) of broilers aged between 26 and 40 days (p < 0.01). BC and TB also displayed a significant interaction in relation to serum malondialdehyde levels and total antioxidant capacity (p < 0.05). Additionally, there was a significant interaction between BC and TB concerning the duodenal villus-to-crypt ratio, crypt depth, and jejunal villus-to-crypt ratio (p < 0.05). The addition of BC and TB significantly enhanced the richness and diversity of cecal microbiota, with a notable interactive effect observed for the abundance of Faecalibacterium, Ruminococcus_torques_group, and Phascolarctobacterium. In conclusion, supplementation with BC and TB can effectively improve the growth performance, serum antioxidant capacity, intestinal morphology, and cecal microbiota composition of yellow-feathered broilers, indicating the presence of an interactive effect.
... Research in which Bacillus coagulans was evaluated in diets for broilers observed an increase in the population of Lactobacillus spp. and inhibition of Escherichia coli replication in the cecum (XU et al. 2017) and a higher incidence of Lactobacillus and Bifidobacterium, in addition to a lower incidence of Salmonella Enteritidis in the cecum (ZHEN et al. 2018) of birds that received the probiotic in the diet. These results demonstrate the effectiveness of this probiotic in promoting the intestinal health of birds as it stimulates the colonization of bacteria producing organic acids, which leads to a reduction in the pH of the intestinal environment, with consequent inhibition of the population of pathogenic bacteria (HUNG et al. 2012). ...
Article
Full-text available
The use of antimicrobial growth promoters in broiler feed has been beneficial for improving performance and preventing diseases. However, the indiscriminate use of these products in the feed can result in the development of resistant bacteria, the accumulation of residues in the products, and an imbalance in the microflora of birds. Therefore, it is necessary to evaluate alternatives, such as beneficial microorganisms that improve microbial growth without affecting animal health and product quality. This research aimed to evaluate the supplementation with the probiotic Bacillus coagulans on the performance, carcass characteristics, and health of broilers from seven to 42 days. In total, 720 broilers were used, distributed in a randomized block design with six treatments and eight replicates. The evaluated treatments were as follows: Control ration (RC); PROB1 (Probiotic 400 g/t); PROB2 (Probiotic 400 g/t until 21 days and 200 g/t from 22 to 42 days); RC + antibiotic; RC + Salmonella inoculation; PROB1 + Salmonella inoculation. The treatments did neither influence feed intake, carcass yield, and cuts nor the incidence of injuries to the chest, hock, and footpad. Weight gain and feed conversion were better in birds that received antibiotic or probiotic diets. There was an incidence of Salmonella in the e challenges excreta at 42 days only in the treatment with challenge without adding probiotics. We conclude that the probiotic Bacillus coagulans can be used as an alternative to antibiotics in the diet of broilers as it facilitates similar performance and is efficient in the control of Salmonella Enteritidis.
... However, Bacillus coagulans ATCC7050 had no significant effect on jejunum crypt depth in 1-day-old broilers was found by Hung et al. (Hung et al. 2012). L. Xu et al. showed that chicks fed a diet with 200 mg/kg of Bacillus coagulans significantly increased the villus height/crypt depth ratio at the duodenum compared to the group fed only a basal diet, the amount of the secretory immunoglobulin SIgA has also observed a significant increase (Xu et al. 2017). In a study by Y.Y. ...
Article
Full-text available
Purpose Products enriched with probiotics have always been fashionable. Weizmannia coagulans has become a hot research topic in the academic community due to their multiple functional properties and high resistance to stress, which can retain their activity in a variety of harsh environments. This review aims to evaluate the probiotic effects of different strains of Weizmannia coagulans in animals and humans and to inspire better exploitation of the value of this strain. Methods This review summarizes the latest research progress of Weizmannia coagulans from two major applications in animal breeding and human health. Results The functional properties of Weizmannia coagulans are extensively recognized. In animals, the strain can promote nutrient absorption, reduce mortality, and enhance the slaughter rate in livestock and poultry. In humans, the strain can be used to treat gastrointestinal disorders, immunomodulation, depressive symptoms, and non-alcoholic fatty liver. Weizmannia coagulans is projected as an ideal substitute for antibiotics and other chemical drugs. Conclusion Despite the outstanding functional properties of Weizmannia coagulans , there are numerous strains of Weizmannia coagulans and significant differences between strains in functional and physiological properties. Currently, there are few literature reports on the probiotic mechanism and functional gene identification of Weizmannia coagulans , which is crucial for the commercialization of Weizmannia coagulans and the benefit of human society.
... Bacillus-based probiotics are widely used as alternatives to antibiotics in animal and chicken feed due to their capacity to form spores, which produce resistance against high temperatures, pH, bile and enzymes encountered in the gastrointestinal tract (GIT), withstand harsh conditions and confer health benefits to the host [12,13]. Previous studies showed that supplementation with Bacillus-based probiotics had positive effects on the growth performance, immunity, gut homeostasis and microbiota of fishes, piglets and chickens [14][15][16]. ...
Article
Full-text available
Coccidiosis is a well-known poultry disease that causes the severe destruction of the intestinal tract, resulting in reduced growth performance and immunity, disrupted gut homeostasis and perturbed gut microbiota. Supplementation of probiotics were explored to play a key role in improving growth performance, enhancing innate and adaptive immunity, maintaining gut homeostasis and modulating gut microbiota during enteric infection. This study was therefore designed to investigate the chicken gut whole microbiota responses to Bacillus subtilis (B. subtilis) probiotic feeding in the presence as well as absence of Eimeria infection. For that purpose, 84 newly hatched chicks were assigned into four groups, including (1) non-treated non-challenged control group (CG − ET), (2) non-treated challenged control group (CG + ET), (3) B. subtilis-fed non-challenged group (BS − ET) and (4) B. subtilis-fed challenged group (BS + ET). CG + ET and BS + ET groups were challenged with Eimeria tenella (E. tenella) on 21 day of housing. Our results for Alpha diversity revealed that chickens in both infected groups (CG + ET and BS + ET) had lowest indexes of Ace, Chao 1 and Shannon, while highest indexes of Simpson were found in comparison to non-challenged groups (CG − ET and BS − ET). Firmicutes was the most affected phylum in all experimental groups following Proteobacteria and Bacteroidota, which showed increased abundance in both non-challenged groups, whereas Proteobacteria and Bacteroidota affected both challenged groups. The linear discriminant analysis effect size method (lEfSe) analysis revealed that compared to the CG + ET group, supplementation of probiotic in the presence of Eimeria infection increased the abundance of some commensal genera, included Clostridium sensu stricto 1, Corynebacterium, Enterococcus, Romboutsia, Subdoligranulum, Bacillus, Turicibacter and Weissella, with roles in butyrate production, anti-inflammation, metabolic reactions and the modulation of protective pathways against pathogens. Collectively, these findings evidenced that supplementation of B. subtilis probiotic was positively influenced with commensal genera, thereby alleviating the Eimeria-induced intestinal disruption.
Article
Background: Evidence suggests that Bacillus coagulans TBC169 can improve intestinal motility. Aim: To investigate the effectiveness and safety of Bacillus coagulans TBC169 probiotics in promoting the recovery of intestinal function after gynecological laparoscopic surgery. Method: Patients who underwent laparoscopic surgeries due to gynecological diseases were randomly assigned to the high-dose, conventional-dose, and the placebo-control groups (1:1:1 ratio). The primary outcome was the time to the first passage of flatus time (FFT). Secondary outcomes were the time to the first defecation (FDT), the time to the first bowel sounds (TFBS), the duration of hospital stay (DHS), and the incidence of postoperative adverse events (AEs). Results: Compared to the placebo-control group, shorter FFT values were observed in the conventional-dose (23.15 h vs. 29.10 h, P < 0.05) and high-dose (19.15 h vs. 29.10 h, P < 0.001) groups. Similar trends were observed regarding TFBS in the conventional-dose (18.50 h vs. 21.10 h, P < 0.05) and high-dose (15.20 h vs. 21.10 h, P < 0.001) groups. There were no significant differences in FFT and TFBS between the intervention groups. Compared to the placebo-control group, lower incidences of postoperative adverse events were observed in the conventional-dose (12.50% vs. 40.00%, P < 0.05) and the high-dose (5.00% vs. 40.00%, P < 0.001) groups. However, there were no significant differences between these intervention groups. Conclusion: Bacillus coagulans TBC169 probiotics can accelerate intestinal function recovery, and reduce postoperative adverse events in patients after gynecological laparoscopic surgery. The study protocol was registered at the Chinese Clinical Trial Registry (ChiCTR2200059518).
Article
Full-text available
Components of the commensal flora, including Bifidobacteria and Lactobacilli, have been associated with beneficial effects on the host. These beneficial effects include maintenance of intestinal homeostasis, competitive exclusion of pathogens, production of antimicrobial compounds, promotion of gut barrier function, and immune modulation. Probiotics currently can be administered in dairy yogurts and drinks and also in the form of sachets or capsules. Although preliminary studies are clearly promising, placebo-controlled, randomized, double-blind clinical trials are required to clarify the role of probiotic bacteria in the treatment of inflammatory bowel disease. The choice of probiotic bacteria, the optimal dose, mode of administration, and duration of therapy still need to be established. Detailed strain characterization is also required for all potential probiotic strains. As evidence accumulates to suggest a breakdown in tolerance toward ubiquitous intestinal bacteria, it appears logical to intervene by modulating the enteric flora. Increasingly, research suggests that probiotics may offer an alternative or adjuvant approach to conventional therapy by altering the intestinal microflora and modulating the host immune system.
Article
Full-text available
Two hundred eighty-eight 1-d-old male Arbor Acres broilers were randomly allocated to 4 treatments to examine the effect of using Bacillus amyloliquefaciens-based direct-fed microbials (DFM) to replace antibiotics in the late growth stage on performance, nutrient digestibility, cecal microflora, and intestinal morphology in broilers. The experimental diets were (1) a negative control (NC) group fed a basal diet without any antibiotics; (2) a positive control (PC) group fed the basal diet with 200 mg/kg of zinc bacitracin; (3) a test group fed the basal diet with 200 mg/kg of zinc bacitracin from d 1 to 21 and 30 mg/kg of DFM from d 22 to 42 (DFM30); and (4) a test group fed the basal diet with 200 mg/kg of zinc bacitracin from d 1 to 21 and 60 mg/kg of DFM from d 22 to 42 (DFM60). The results showed that DFM30 and DFM60 increased BW gain and improved FCR as compared with NC group (P < 0.05). Generally, the PC, DFM30, and DFM60 groups showed increased apparent total tract nutrient digestibility for DM, CP, and AME as compared with the NC group. Both the DFM30 and DFM60 groups decreased cecal Escherichia coli population as compared with the NC group, and increased the population of Lactobacillus as compared with the PC group. The PC, DFM30, and DFM60 groups increased villus height and the ratio of villus height to crypt depth compared with NC. In conclusion, dietary supplementation with B. amyloliquefaciens-based DFM during d 22 to 42 may enhance performance by increasing nutrient digestibility and improving intestinal health in birds fed diets supplemented with zinc bacitracin from d 1 to 21.
Article
Full-text available
Probiotics are live microorganisms that provide health benefits to the host when ingested in adequate amounts. The strains most frequently used as probiotics include lactic acid bacteria and bifidobacteria. Probiotics have demonstrated significant potential as therapeutic options for a variety of diseases, but the mechanisms responsible for these effects have not been fully elucidated yet. Several important mechanisms underlying the antagonistic effects of probiotics on various microorganisms include the following: modification of the gut microbiota, competitive adherence to the mucosa and epithelium, strengthening of the gut epithelial barrier and modulation of the immune system to convey an advantage to the host. Accumulating evidence demonstrates that probiotics communicate with the host by pattern recognition receptors, such as toll-like receptors and nucleotide-binding oligomerization domain-containing protein-like receptors, which modulate key signaling pathways, such as nuclear factor-ĸB and mitogen-activated protein kinase, to enhance or suppress activation and influence downstream pathways. This recognition is crucial for eliciting measured antimicrobial responses with minimal inflammatory tissue damage. A clear understanding of these mechanisms will allow for appropriate probiotic strain selection for specific applications and may uncover novel probiotic functions. The goal of this systematic review was to explore probiotic modes of action focusing on how gut microbes influence the host.
Article
Full-text available
The present study was conducted to evaluate the effect of the dietary supplementation of Bacillus amyloliquefaciens-based direct-fed microbial (DFM) on growth performance, nutrient utilization, intestinal morphology and cecal microflora in broiler chickens. A total of two hundred and eighty eight 1-d-old Arbor Acres male broilers were randomly allocated to one of four experimental treatments in a completely randomized design. Each treatment was fed to eight replicate cages, with nine birds per cage. Dietary treatments were composed of an antibiotic-free basal diet (control), and the basal diet supplemented with either 15 mg/kg of virginiamycin as antibiotic growth promoter (AGP), 30 mg/kg of Bacillus amyloliquefaciens-based DFM (DFM 30) or 60 mg/kg of Bacillus amyloliquefaciens-based DFM (DFM 60). Experimental diets were fed in two phases: starter (d 1 to 21) and finisher (d 22 to 42). Growth performance, nutrient utilization, morphological parameters of the small intestine and cecal microbial populations were measured at the end of the starter (d 21) and finisher (d 42) phases. During the starter phase, DFM and virginiamycin supplementation improved the feed conversion ratio (FCR; p
Article
Full-text available
Dendritic cells (DCs) are professional antigen-presenting cells that play a critical role to activate immune response. They may be targeted for immunomodulation by microbes, including probiotics. In this study, chicken bone marrow dendrite cells (chi-BMDCs) were stimulated with lipopolysachride (LPS), Saccharomyces boulardii (Sb), Bacillus subtilis B10 (Bs), co-culture of Sb + Bs and phosphate buffer saline (PBS) as a control group (Ctr) at 3 h, 6 h and 12 h intervals. Results revealed that treatment groups modulated the phenotype and biological functions of chi-BMDCs. Scan electron microscopy showed attachment of probiotics on the surface of chi-BMDCs. Additionally transmission electron microscopy (TEM) revealed efficiently engulfing and degradation of probiotics. Gene expression levels of MHC-II, CD40, CD80 and CD86 up-regulated in stimulated groups. Furthermore, toll-like receptors TLR1, TLR2, TLR4 and chicken specific TLR15 expressions were improved and downstream associated factors MyD88, TRAF6, TAB1 and NFκ-B mRNA levels increased in all treatment groups as compared to control. Surprisingly, NFκ-B response was noted significant higher in LPS treatment among all groups. Moreover, IL-1β, IL-17, IL-4, TGF-β and IL-10 production levels were found higher, and lower concentration of INF-γ and IL-8 were observed in Sb, Bs and Sb + Bs treatment groups. In contrast, LPS groups showed prominent increase in IL-12, INF-γ and IL-8 concentration levels as compared to control group. Altogether, these results emphasize a potentially important role of Saccharomyces boulardii and Bacillus subtilis B10 in modulating immunological functions of chi-BMDCs by targeting specific toll like receptors (TLRs) and associated factors. The role of probiotics on chi-BMDCs functionality in a non-mammalian species have been presented for the first time. J. Cell. Biochem. © 2013 Wiley Periodicals, Inc.
Article
Full-text available
An experiment was conducted to compare the effect of non-encapsulated liquid lactic acid produced by Bacillus coagulans fermented molasses and its encapsulated form of lactic acid on broiler performances, intestinal characteristics and intestinal microflora. Ninety six 1-day-old COBB broiler chicks were subjected to 8 different dietary groups, namely 2 forms of acidifier (non-encapsulated liquid and encapsulated) lactic acid and 4 levels of inclusion (0.2, 0.4, 0.6 and 0.8%). The results showed that encapsulated lactic acid significantly improved (P < 0.01) broiler performances, reduced (P < 0.05) intestinal pH, increased (P < 0.05) intestinal villi length and reduced (P < 0.05) only the number of Salmonella sp. With regard to level of lactic acid in the diet, it significantly affected (P < 0.01) villi number and length, the number of lactic acid bacteria, and Escherichia coli. It is concluded that the use of 0.6% encapsulated lactic acid might be included in the broiler diet to improve performances.
Article
This article provides an overview of how intestinal epithelial cells (IEC) recognize commensals and how they maintain host-bacterial symbiosis. Endocrine, goblet cells, and enterocytes of the intestinal epithelium express a range of pattern recognition receptors (PRR) to sense the presence of microbes. The best characterized are the Toll-like receptors (TLR) and nucleotide oligomerization domain-like receptors (NLR), which play a key role in pathogen recognition and the induction of innate effectors and inflammation. Several adaptations of PRR signaling have evolved in the gut to avoid uncontrolled and potentially destructive inflammatory responses toward the resident microbiota. PRR signaling in IEC serve to maintain the barrier functions of the epithelium, including the production of secretory IgA (sIgA). Additionally, IECs play a cardinal role in setting the immunosuppressive tone of the mucosa to inhibit overreaction against innocuous luminal antigens. This includes regulation of dendritic cells (DC), macrophage and lymphocyte functions by epithelial secreted cytokines. These immune mechanisms depend heavily on IEC recognition of microbes and are consistent with several studies in knockout mice that demonstrate TLR signaling in the epithelium has a profoundly beneficial role in maintaining homeostasis
Article
The development of a low-cost polymer-grade l-lactic acid production process was achieved in this study. Excess sludge hydrolyzate (ESH) was chosen as nutrient source for the objective of reducing nutrient cost in lactic acid production. 1% of ESH had high performance in lactic acid production relative to 2g/l yeast extract (YE) while the production cost of ESH was much lower than that of YE, indicating ESH was a promising substitute of YE. By employing a thermophilic strain of Bacillus coagulans (NBRC 12583), non-sterilized batch and repeated batch l-lactic acid fermentation was successfully performed, and the optical purity of l-lactic acid accumulated was more than 99%. Moreover, the factors associated with cell growth and lactic acid fermentation was investigated through a two-stage lactic acid production strategy. Oxygen played an important role in cell growth, and the optimal condition for cell growth and fermentation was pH 7.0 and 50°C.
Article
Interferons (IFNs) are produced in response to virus infection and induce an antiviral state in virtually all cell types. In addition to upregulating the transcription of genes that inhibit virus replication, type I (or -α/β) IFNs also act to orchestrate the adaptive immune response to virus infection. Recently a new family of antiviral cytokines, the type III (or -λ) IFNs, has been identified that activate the same antiviral pathways via a distinct receptor. Although the identical transcription factor, IFN-stimulated gene factor 3 is activated by either IFN-α/β or IFN-λ signaling, differences in the induction and action of these two cytokine families are beginning to be appreciated. In this article, we review this emerging body of literature on the differing roles these cytokines play in host defense of the mucosal surface. Although many viruses enter the body through the respiratory and gastrointestinal tracts, we have focused the discussion on influenza A virus, respiratory syncytial virus, and rotavirus, three ubiquitous human pathogens that target the epithelial lining and are associated with a major disease burden.